- Alimta news are updated once a hour
- We deliver news from more than 500 sources on alimta
NewsAdvertisers: |
Lilly Raises 2006 Earnings Forecast by 63 Percent (Update2)...
Bloomberg.com:
U.S. Updated: New York: Dec 09 10:00London: Dec 09 15:00Tokyo: Dec 10 00:00 US AUBZFPGRHKIMJPLNSMIND : Regions Top Worldwide Regions Asia Australia & New Zealand Canada Europe Germany Japan Latin America U.K. U.S. Markets Economy/Politics Commentary Sports Culture RESOURCES: Bloomberg TV Bloomberg Radio Markets U.S. E-Mail This Story Printer-Friendly Format Consumer Confidence in U.S. Rises a Second Month as Gasoline Prices Ease U.S. Treasuries Fall After Consumer Confidence Index Rises in December Alltel to Exit Fixed-Line Business in $9.1 Billion Transaction With Valor Lilly Raises 2006 Earnings Forecast by 63 Percent (Update2) Dec. 9 (Bloomberg) - Eli Lilly & Co., maker of the top- selling schizophrenia drug Zyprexa, raised its 2006 earnings forecast by 63 percent to reflect rising sales of its newest products. Net income next year will increase to $3.10 to $3.20 a share, up from an October forecast of $1.90 to $1.96, Indianapolis-based Lilly said today in a statement before meeting with investors in New York. Earnings in 2004 were $1.81 billion, or $1.66 a share. Under Chief Executive Officer Sidney Taurel, Lilly has beaten earnings estimates at least six quarters in a row. Taurel and executives are briefing investors on his plans to expand sales of Lilly's newest drugs. Demand for the cancer treatment
Lilly Raises 2006 Earnings Forecast by 63 Percent (Update3)...
Bloomberg.com:
U.S. Updated: New York: Dec 09 10:00London: Dec 09 15:00Tokyo: Dec 10 00:00 US AUBZFPGRHKIMJPLNSMIND : Regions Top Worldwide Regions Asia Australia & New Zealand Canada Europe Germany Japan Latin America U.K. U.S. Markets Economy/Politics Commentary Sports Culture RESOURCES: Bloomberg TV Bloomberg Radio Markets U.S. E-Mail This Story Printer-Friendly Format Consumer Confidence in U.S. Rises a Second Month as Gasoline Prices Ease U.S. Treasuries Fall After Consumer Confidence Index Rises in December Alltel to Exit Fixed-Line Business in $9.1 Billion Transaction With Valor Lilly Raises 2006 Earnings Forecast by 63 Percent (Update3) Dec. 9 (Bloomberg) - Eli Lilly & Co., maker of the top- selling schizophrenia drug Zyprexa, raised its 2006 earnings forecast by 63 percent to reflect expanding sales of its newest products. Net income next year will increase to $3.10 to $3.20 a share, up from an October forecast of $1.90 to $1.96, Indianapolis-based Lilly said today in a statement before meeting with investors in New York. Earnings in 2004 were $1.81 billion, or $1.66 a share. Under Chief Executive Officer Sidney Taurel, Lilly has beaten earnings estimates at least six quarters in a row. Taurel and executives are briefing investors on his plans to increase sales of Lilly's newest drugs. Demand for the cancer treatment
Lilly sees profit topping Wall Street...
ABC News: Lilly sees profit topping Wall Street
/* */
ABC News Home
December 9, 2005 | Get Your Local News and Weather
Search ABC NewsSearch the Web
Home
U.S. International Money Technology & Science Health Entertainment Politics ESPN Sports Travel Local News & Weather Video & Audio Good Morning America World News Tonight 20/20 Primetime Nightline World News Now This Week ABC News Home on Friday said 2006 earnings should top Wall Street forecasts on growing demand for its new drugs and stabilizing U.S. sales of its Zyprexa schizophrenia treatment, sending shares higher in pre-market trade. The Indianapolis drugmaker, whose shares were up 3.4 percent, said it expects 2006 earnings of $3.10 to $3.20 per share, excluding special items. 'Working Wounded': Constructive Criticism Natural-Gas Prices Hit a Record High Shopping Undercover That translates into growth of 8 percent to 12 percent over expected 2005 results, the company said in a release. "This growth rate is nearly double the average Wall Street consensus forecast for large-cap pharmaceutical companies," Lilly said. Analysts polled by Reuters Estimates on average have forecast earnings of $3.08 per share for next year. The company said fourth-quarter 2005 and full-year 2005 earnings should to be at the "high" end of the company's previous forecast range... 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news |